Health Effects of a Nordic Diet Rich in Plant-based Foods and Fish
1 other identifier
interventional
111
1 country
1
Brief Summary
The purpose of this study is to investigate the effects of a Nordic diet rich in plant-based foods and fish on indicators of cardiovascular disease risk at two different levels of salt intake. The study is a 20-wk randomized controlled crossover trial. The subjects follow a salt-restricted diet during the study. The study begins with a 4-wk run-in phase for all subjects. After that the subjects are randomly allocated to one of two groups. Group 1 consumes a healthy Nordic low-salt diet enriched with plant-based foods and fish for 16 weeks. Group 2 consumes a low-salt diet for 16 weeks. During the 16 weeks, both groups receive salt and placebo capsules in a double-blind, crossover fashion (8+8 weeks).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2011
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedFirst Submitted
Initial submission to the registry
August 3, 2011
CompletedFirst Posted
Study publicly available on registry
August 9, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2014
CompletedOctober 15, 2014
October 1, 2014
1.4 years
August 3, 2011
October 13, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline in systolic and diastolic blood pressure after treatments
12 and 20 weeks
Secondary Outcomes (4)
Change from baseline in PFA-100 measurements after treatments
12 and 20 weeks
Change from baseline in biomarkers of cardiovascular disease risk after treatments
12 and 20 weeks
Change from baseline in nutritional biomarkers after treatments
12 and 20 weeks
Change from baseline in blood cell gene expression after treatments
12 and 20 weeks
Study Arms (2)
Plant-based food and fish with salt restr.
ACTIVE COMPARATORThe subjects consume plant based foods (fruits, berries, vegetables, whole grain) and fish in addition to a salt-restricted diet. Intake of salt is normal to high for 8 weeks and low for 8 weeks (subjects receive salt and placebo capsules in a crossover design).
Diet with salt restriction
PLACEBO COMPARATORThe subjects follow a salt-restricted diet. Intake of salt is normal to high for 8 weeks and low for 8 weeks (subjects receive salt and placebo capsules in a crossover design).
Interventions
The intervention lasts for 20 weeks and it includes dietary counseling concerning salt restriction. Key foods are provided to the subjects.
Eligibility Criteria
You may qualify if:
- prehypertension or hypertension (systolic blood pressure 130-159 mmHg or diastolic blood pressure 85-99 mmHg)
You may not qualify if:
- smoking
- regular use of medications
- intestinal disorders
- symptomatic cardiovascular disease
- obesity (BMI\>35 kg/m2)
- vegetarianism
- high intake of alcohol
- allergy to fish
- pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Finnish Institute for Health and Welfarelead
- Academy of Finlandcollaborator
- University of Oslocollaborator
Study Sites (1)
National Institute for Health and Welfare
Helsinki, FI-00271, Finland
Related Publications (1)
Niiranen T, Erlund I, Jalkanen S, Jula A, Salmi M. Effects of altered salt intake and diet on cytokines in humans: A 20-week randomized cross-over intervention study. Eur J Immunol. 2023 Jan;53(1):e2250074. doi: 10.1002/eji.202250074. Epub 2022 Nov 20.
PMID: 36330564DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Iris Erlund, Dr.
Finnish Institute for Health and Welfare
- STUDY DIRECTOR
Antti Jula, Dr.
Finnish Institute for Health and Welfare
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD., senior researcher
Study Record Dates
First Submitted
August 3, 2011
First Posted
August 9, 2011
Study Start
January 1, 2011
Primary Completion
June 1, 2012
Study Completion
September 1, 2014
Last Updated
October 15, 2014
Record last verified: 2014-10